Senior insider sale
XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$309.2K
42.50K shares
What this filing means
HALKUFF DAWN plans to sell 42.50K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $309.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2025ACC: 0001950047-25-005670
Director
Since Oct 2021
42.50K
Shares to sell
$309.2K
Approx. market value
42.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
6/5/2024
42.50KTotal acquired42.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/5/2024 | Restricted stock vesting under a registered plan Not Applicable | 42.50K | — |
| Total | 42.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
42.50K
Market value
$309.2K
8/12/2025
Total
Units
42.50K
Value
$309.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/12/2025 | 42.50K | $309.2K | NASDAQ | Planned |
| Total | 42.50K | $309.2K | ||